Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid

Archives of Dermatology

Volumn 139, Issue 6, 2003, Pages 813-815

  Chu, Josephine ^a   Bradley, Maria ^a   Marinkovich, M Peter ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE; PREDNISONE; TACROLIMUS; TETRACYCLINE;

ADULT; AGED; ARTICLE; CASE REPORT; DRUG RESPONSE; FEMALE; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; MALE; PEMPHIGOID; PRIORITY JOURNAL; TREATMENT OUTCOME; URTICARIA;

ADMINISTRATION, TOPICAL; AGED; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; TACROLIMUS;

EID: 0038797070     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.6.813     Document Type: Article

References (5)

1. Nousari HC, Anhalt GJ. Pemphigus and bullous pemphigoid. Lancet. 1999;354:667-672.
2. Joly P, Roujeau JC, Benichou J, et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med. 2002;346:321-327.
3. Khumalo NP, Murrell DF, Wojnarowska F, Kirtschig G. A systematic review of treatments for bullous pemphigoid. Arch Dermatol. 2002;138:385-389.
4. Ling MR. Topical tacrolimus and pimecrolimus: future directions. Semin Cutan Med Surg. 2001;20:268-274.
5. Skaehill PA. Tacrolimus in dermatological disorders. Ann Pharmacother. 2001;35:582-587.